← Retour à la une
États-Unis · Agences & temps réel · PR Newswire

Ionis Pharmaceuticals, Inc. (IONS) Securities Investigation Notice - Levi & Korsinsky

Publié par PR Newswire · États-Unis il y a 19 min
Ionis Pharmaceuticals, Inc. (IONS) Securities Investigation Notice - Levi & Korsinsky
PR Newswire

Résumé détaillé

TRYNGOLZA sales fell to $9.3 million from $31.8 million a year earlier, and IONS shares dropped on the product-level numbers. Levi & Korsinsky is investigating potential…

TRYNGOLZA sales fell to $9.3 million from $31.8 million a year earlier, and IONS shares dropped on the product-level numbers. Levi & Korsinsky is investigating potential securities law violations on behalf of shareholders who lost money.

NEW YORK, Nov. 16, 2026 /PRNewswire/ -- Sellers drove Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) shares sharply lower on November 9, 2026, after the Company reported third-quarter TRYNGOLZA sales of $9.3 million and cut the drug's full-year sales guidance to roughly $50 million from $100-$110 million. If you bought IONS and are now holding losses, you may have legal rights, and Levi & Korsinsky is investigating. IONS shareholders who lost money are encouraged to submit their loss details for a free review . You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

Ionis beat consensus estimates on both revenue and earnings per share. Shares fell anyway. Third-quarter commercial revenue rose 18% year over year, which the Company attributed primarily to DAWNZERA product sales. TRYNGOLZA sales, however, were only $9.3 million, compared with $31.8 million in the third quarter of 2025.

TRYNGOLZA recorded approximately $32 million in first-half 2026 sales. To reach the prior $100-$110 million target, the drug needed roughly $68-$78 million over the final six months. The third quarter delivered $9.3 million. The revised full-year figure of roughly $50 million sits $50-$60 million below the original range.

If you are holding IONS losses after the November 9 sell-off, see if you may be eligible to recover your IONS losses or call (212) 363-7500.

ABOUT THE FIRM -- For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years.

Q: How much did IONS stock drop? A: IONS shares fell roughly $7.27, or about 18.44% to open at approximately $32.15 on November 9, 2026, after the Company disclosed that it had cut its…

Q: Which…

Début de l'article, extrait de PR Newswire. Pour lire la suite, ouvrez l'article chez le média.

Lire l'article complet sur PR Newswire Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.prnewswire.com)

À lire aussi